There are many estimates of biological age and they disagree with each other. What to do about it, and what to watch instead.
Biological age is an attempt to describe, in one number, how far a body has travelled along ageing. The idea is easy to follow: the calendar is the same for everyone, bodies are not. The trouble starts when that number is read as a verdict or as a prize.
Why the estimates disagree
Biological age is not measured — it is estimated, by a model. There are many models, built on different inputs: some on blood chemistry, some on physical measures, some on epigenetic marks. Each carries its own assumptions and its own training population, so two calculators can legitimately return different numbers from the same lab panel. That is not one of them being broken; they are answering slightly different questions.
What to do about it
Watch the direction, not the absolute value — and only inside a single model. "Three years younger" between two different methods means nothing. The same estimate, computed twice six months apart by the same method, does say something.
And remember the model computes from what you gave it. A missing marker does not make the result more honest; it makes it more confident than it deserves to be.
A longer explanation of how these estimates are built is in Biological age: what it is and how it is measured.
Articles in this section are educational and are not medical advice, a diagnosis, or a prescription. Consult a qualified professional before acting on anything you read here.
Read next
ResearchMedicine and treatmentHealth news, 16 October 2026: an FDA approval in dMMR colon cancer, an oral IL-23 blocker, and a microRNA model after a positive FIT
Five events from the past two weeks: FDA approval of atezolizumab after surgery for stage III dMMR colon cancer, a phase 2 NEJM trial of oral icotrokinra in ulcerative colitis, a plasma microRNA model after a positive FIT, leg alignment after ACL surgery in teenagers, and biological age in 326,000 people.
8 min read
ResearchMedicine and treatmentStem-cell neurons for Parkinson's disease: what the first human trials measured
In 2025 two small trials grafted dopamine-producing cells grown from stem cells into people with Parkinson's disease. What they measured, in whom, why fetal-tissue grafts failed under sham control, and what the phase 3 trial now has to show.
8 min read
ResearchBiomarkersBiological age from a CT scan, an ECG or an X-ray: what the new age models measure
Models can now estimate an "age" from a CT scan, a chest X-ray, an ECG or a photo of the retina. An older-looking result has been linked to higher disease and death risk, but only as an association, in specific populations, and with no evidence that changing the number helps.
8 min read